| 25021-223 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Sagent Pharmaceuticals |
| 25021-223-20 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Sagent Pharmaceuticals |
| 25021-229 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Sagent Pharmaceuticals |
| 25021-229-05 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Sagent Pharmaceuticals |
| 61703-155 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-155-01 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-303 | Cytarabine Injection | Hospira, Inc. |
| 61703-303-46 | Cytarabine Injection | Hospira, Inc. |
| 61703-304 | Cytarabine Injection | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-304-36 | Cytarabine Injection | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-305 | Cytarabine Injection | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-305-38 | Cytarabine Injection | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-305-58 | Cytarabine Injection | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-319 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-319-22 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 63323-120 | Cytarabine Injection | Fresenius Kabi USA, LLC |
| 63323-120-20 | Cytarabine Injection | Fresenius Kabi USA, LLC |
| 68083-337 | Cytarabine Injection Rx only For Intravenous, Intrathecal and Subcutaneous Use Only. | Gland Pharma Limited |
| 68083-337-01 | Cytarabine Injection Rx only For Intravenous, Intrathecal and Subcutaneous Use Only. | Gland Pharma Limited |
| 68083-343 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only Rx only | Gland Pharma Limited |
| 68083-343-01 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only Rx only | Gland Pharma Limited |
| 68083-343-05 | Cytarabine Injection For Intravenous, Intrathecal and Subcutaneous Use Only Rx only | Gland Pharma Limited |
| 68727-745 | These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017 | Jazz Pharmaceuticals, Inc. | Baxter Oncology GmbH | Jazz Pharmaceuticals Ireland Limited | Jazz Pharmaceuticals Ireland | Almac Sciences Ireland Limited | Charles Rivers Laboratories Ireland Limited | Eurofins BioPharma Product Testing Ireland Limited | Eurofins Lancaster Laboratories Inc. | Millmount Healthcare Limited |
| 68727-745-01 | These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017 | Jazz Pharmaceuticals, Inc. | Baxter Oncology GmbH | Jazz Pharmaceuticals Ireland Limited | Jazz Pharmaceuticals Ireland | Almac Sciences Ireland Limited | Charles Rivers Laboratories Ireland Limited | Eurofins BioPharma Product Testing Ireland Limited | Eurofins Lancaster Laboratories Inc. | Millmount Healthcare Limited |
| 68727-745-02 | These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017 | Jazz Pharmaceuticals, Inc. | Baxter Oncology GmbH | Jazz Pharmaceuticals Ireland Limited | Jazz Pharmaceuticals Ireland | Almac Sciences Ireland Limited | Charles Rivers Laboratories Ireland Limited | Eurofins BioPharma Product Testing Ireland Limited | Eurofins Lancaster Laboratories Inc. | Millmount Healthcare Limited |
| 68727-745-05 | These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017 | Jazz Pharmaceuticals, Inc. | Baxter Oncology GmbH | Jazz Pharmaceuticals Ireland Limited | Jazz Pharmaceuticals Ireland | Almac Sciences Ireland Limited | Charles Rivers Laboratories Ireland Limited | Eurofins BioPharma Product Testing Ireland Limited | Eurofins Lancaster Laboratories Inc. | Millmount Healthcare Limited |
| 71288-108 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD |
| 71288-108-05 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD |
| 71288-108-06 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD |
| 71288-109 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. |
| 71288-109-20 | Cytarabine Injection (For Intravenous, Intrathecal and Subcutaneous Use Only) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. |
| 71288-168 | Cytarabine Injection (For Intravenous or Subcutaneous Use) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. |
| 71288-168-50 | Cytarabine Injection (For Intravenous or Subcutaneous Use) | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. |
| 71288-169 | Cytarabine Injection NOT FOR INTRATHECAL USE - CONTAINS BENZYL ALCOHOL FOR INTRAVENOUS OR SUBCUTANEOUS USE ONLY | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD |
| 71288-169-25 | Cytarabine Injection NOT FOR INTRATHECAL USE - CONTAINS BENZYL ALCOHOL FOR INTRAVENOUS OR SUBCUTANEOUS USE ONLY | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD |